2012
DOI: 10.3109/0886022x.2012.684552
|View full text |Cite
|
Sign up to set email alerts
|

The Pharmacodynamics of Vecuronium in Chronic Renal Failure Patients: The Impact of Different Priming Doses

Abstract: Priming the chronic renal failure patients with 10% of ED(95) vecuronium dose acquit the best pharmacodynamics with the fewest signs of muscle weakness. Larger vecuronium priming doses are unfavorable and convey no more clinical utility.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2014
2014
2015
2015

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 38 publications
(43 reference statements)
0
1
0
Order By: Relevance
“…Vecuronium is a non-depolarising neuromuscular blocking drug, which has minimal cardiovascular effects and lack of dependence on the kidney for elimination (1). But it has a disadvantage of having a relatively slow onset time, around 2-3 minutes with 0.1 mg/kg dose of vecuronium.…”
Section: Introductionmentioning
confidence: 99%
“…Vecuronium is a non-depolarising neuromuscular blocking drug, which has minimal cardiovascular effects and lack of dependence on the kidney for elimination (1). But it has a disadvantage of having a relatively slow onset time, around 2-3 minutes with 0.1 mg/kg dose of vecuronium.…”
Section: Introductionmentioning
confidence: 99%